Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-09-26 00:00:00 ET · period of report 2025-09-25 · accession 0001836067-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-26 | 2025-09-25 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | +1,875 | 11.9K | +19% | $0 |
| D | 2025-09-26 | 2025-09-25 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $46.21 | -840 | 11.0K | -7% | -$38.8K |
| D | 2025-09-26 | 2025-09-25 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | M - OptEx | $0.00 | -1,875 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-25 | M | A | 1,875 | $0.00 | 11,855 | D | — | — | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. |
| 2 | Common | Common Stock | 2025-09-25 | F | D | 840 | $46.21 | 11,015 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Derivative | Performance Share Unit | 2025-09-25 | M | D | 1,875 | $0.00 | 0 | D | $0.00 · — to — | 1,875 Common Stock | (F3) On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |